Skip to main content

Table 1 Demographics of patients with ischemic stroke patients

From: Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial

Variablesa

Aspirin versus warfarin

p value*

Aspirin (n = 23)

Warfarin (n = 33)

Age, years

72.2 ± 8.6

74.2 ± 8.3

0.389

Female, n (%)

11 (47.8)

17 (51.5)

0.786

Clinical Profiles

 CHADS2

3.2 ± 0.9

3.5 ± 0.8

0.232

 CHA2DS2-VASc

4.4 ± 1.3

4.9 ± 1.2

0.238

 NIHSS, initial

6.4 ± 6.2

5.6 ± 6.0

0.613

 mRS, initial

2.3 ± 1.7

2.5 ± 1.7

0.669

Laboratory Data

 White blood cell, × 103/μl

7.8 ± 2.7

7.5 ± 3.2

0.716

 Hematocrit, %

37.0 ± 6.3

37.4 ± 5.7

0.803

 Platelet, ×103/μl

192.8 ± 44.1

219.9 ± 59.1

0.068

 PT, %

93.1 ± 12.0

85.0 ± 12.5

0.051

 aPTT, second

27.1 ± 7.6

30.7 ± 18.1

0.371

 D-dimer, mg/L

2.4 ± 3.6

2.4 ± 2.7

0.959

 Albumin, g/dL

5.6 ± 8.8

5.2 ± 7.2

0.854

 Total protein, g/dL

6.6 ± 0.8

6.7 ± 0.8

0.479

 Creatinine, mg/dL

0.8 ± 0.3

1.3 ± 2.4

0.296

 eGFR, mL/min/1.73m2

84.7 ± 19.0

85.1 ± 17.8

0.940

 Total cholesterol, mg/dL

153.1 ± 30.2

155.3 ± 28.0

0.776

 Triglyceride, mg/dL

95.2 ± 39.8

90.4 ± 36.3

0.638

 High density lipoprotein, mg/dL

47.2 ± 13.9

47.5 ± 14.2

0.951

 HbA1c, %

5.9 ± 0.4

6.0 ± 0.5

0.763

 UACR, mg/g

114.8 ± 116.8

160.8 ± 203.8

0.334

 Homocysteine, μmol/L

16.2 ± 4.6

17.5 ± 13.1

0.654

  1. *Independent T-test was used for numerical values and chi square test for categorical value
  2. a Values are presented mean ± SD, unless indicated otherwise
  3. CHADS2: C congestive heart failure, H hypertension, A ≥75 years; D diabetes mellitus, S2 prior stroke, transient ischemic attack or thromboembolism, CHA2DS2-VASc: C congestive heart failure, H hypertension, A2 ≥75 years, D diabetes mellitus, S2 prior stroke, transient ischemic attack or thromboembolism, V vascular disease, A 65–74 years, Sc sex category, NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, PT prothrombin time, aPTT activated partial thromboplastin time, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, UACR urine albumin-to-creatinine ratio